Fuse Medical, Inc. (FZMD)
OTCMKTS · Delayed Price · Currency is USD
0.0865
0.00 (0.00%)
At close: Aug 22, 2025
Fuse Medical Market Cap
Fuse Medical has a market cap or net worth of $6.25 million as of August 22, 2025. Its market cap has decreased by -48.38% in one year.
Market Cap
6.25M
Enterprise Value
n/a
Revenue
18.40M
Ranking
n/a
PE Ratio
1.81
Stock Price
$0.09
Market Cap Chart
Since January 2, 2018, Fuse Medical's market cap has decreased from 25.50M to 6.25M, a decrease of -75.48%. That is a compound annual growth rate of -16.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 6.25M | 15.40% |
| Dec 31, 2024 | 5.42M | -32.99% |
| Dec 1, 2023 | 8.09M | -23.33% |
| Dec 27, 2022 | 10.55M | -65.07% |
| Dec 30, 2021 | 30.20M | 128.72% |
| Dec 28, 2020 | 13.20M | -37.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |